CVS Health Q4 revenue $83.8B, adjusted EPS $1.99; guides FY23 adj EPS $8.70-$8.90

CVS HEALTH Corp

2022-FY EPS reported $3.14 revenue$322,467,000,000

Q4 revenue $83.8B (+9.5% YoY); GAAP diluted EPS $1.75 vs $0.98; adjusted EPS $1.99.
FY2022 revenue $322.5B (+10.4%); GAAP diluted EPS $3.14; adjusted EPS $8.69.
FY2023 guidance: GAAP EPS $7.73-$7.93, adjusted EPS $8.70-$8.90, cash flow $12.5B-$13.5B.
Quarterly dividend increased 10% effective Feb 1, 2023; new $10B share repurchase program authorized.
Agreement to acquire Signify Health, a leader in home health risk assessments and value-based care.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CVS HEALTH Corp reported financial results for for the three months and year ended December 31, 2022.

Period: for the three months and year ended December 31, 2022
Result: reported results

Exact text from the filing

CVS Health Corporation issued a press release announcing results for the three months and full year ended December 31, 2022.

View on SEC.gov

Browse all earnings releases →

CVS HEALTH Corp filing history →

Source: SEC EDGAR

accession 0000064803-23-000008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.